Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06213974 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Maribavir in Adults and Children With Post-transplant Cytomegalovirus (CMV) Infection in Argentina

Name: A Study of Maribavir in Adults and Children With Post-transplant Cytomegalovirus (CMV) Infection in Argentina — clinical trial record (NCT06213974)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusCompleted

PhaseNot specified

SponsorTakeda

Started2024-09-03

View on ClinicalTrials.gov ↗

The main aim of this study is to learn about the safety of Maribavir in adults and children with post-transplant CMV infection in routine clinical practice in Argentina. The other aim is to study the effectiveness of the treatment with Maribavir in routine clinical practice in Argentina. Participants will be treated by their doctors according to normal medical practice. Study data will be collected either from information already available in the medical records or during study conduct.

Amendment history 2 changes detected by DataLookout

2026-08-22

Trial completed

2026-08-22

Enrollment increased: 10 → 28 participants

Trial Details

NCT Number	NCT06213974
Lead Sponsor	Takeda
Conditions	Cytomegalovirus (CMV)
Enrollment	28 participants
Start Date	2024-09-03
Primary Completion	2026-07-17 (estimated)
Study Completion	2026-07-17 (estimated)
Updated on ClinicalTrials.gov	2026-08-21